v3.26.1
Schedule of Deferred tax assets and liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Income Tax Disclosure [Abstract]    
Net operating loss carryforwards $ 137,964 $ 121,804
Research and development tax credit carryforwards 4,346 5,674
Stock-based compensation expense 20,301 17,717
Intangible assets 3,028
Deferred revenue 1,364 1,469
Capitalized research and development 16,086 22,903
IRC Section 163j interest 4,612 1,471
Other 10,897 7,341
Total deferred tax assets 195,570 181,407
Intangible assets (3,006)
Total deferred tax liabilities (3,006)
Valuation allowance (192,576) (181,416)
Net deferred tax liabilities $ (12) $ (9)